Narin Sadikoğlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Narin Sadikoğlu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ali Şen
Marmara Üniversitesi
1 shared publication - Betül Nur Yaşar
Marmara University
1 shared publication - Duygu Mısırlı
Department of Biochemistry, Hamidiye Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey
1 shared publication - Leyla Bitiş
Marmara University
1 shared publication - Mahfuz Elmastas
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, HAMİDİYE ECZACILIK FAKÜLTESİ, HAMİDİYE ECZACILIK PR
1 shared publication - Mehmet Sina İçEn
Inonu University
1 shared publication
Latest Publications
- 11 May 2026
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 30 (3) , 762-772
Phytochemical Analysis and In Vitro Biological Activities of Three Endemic Origanum species
Origanum species (oregano), which have been used as spices and medicines since ancient times and are one of the important riches of our country, are also known as important species in terms of the bioactive compounds they contain. In this study, phytochemical contents and biological activities of methanol extracts (OMİN, OSAM and OSOM) obtained from the aerial parts of three endemic Origanum species, Origanum minutiflorum, O. saccatum and O. solymicum, were comparatively analyzed. Extracts were obtained by maceration method. Antioxidant, anti-inflammatory and antidiabetic activities were evaluated using DPPH/ABTS radical, 5-lipoxygenase and α- glucosidase inhibition methods, respectively. Total phenol, flavonoid and triterpene contents were calculated by Folin-Ciocalteu, AlCl3 and Acetic acid/Vanillin/perchloric acid methods, respectively. Phenolic compounds of the active extract were analyzed by HPLC. OSAM with IC50 values of 13.51 µg/mL and 81.23 µg/mL exhibited the strongest antioxidant activity against DPPH and ABTS radicals. OSAM with IC50 value of 84.11 µg/mL and OSOM with IC50 value of 102.00 µg/mL showed the best inhibitory activity against α-glucosidase and 5-lipoxygenase enzymes, respectively. Total phenol and flavonoid content was highest in OSAM (132.30 and 60.32 mg/g) while total triterpene content was highest in OMIN (177.39 mg/g). In the HPLC analysis of the most active OSAM, rosmarinic acid as the major compound was detected in very high amounts (211.061 mg/g extract). These results show that OSAM has a strong antioxidant and antidiabetic activity and that other phenolic acids and flavonoids, especially rosmarinic acid, may be responsible for this activity. However, in vivo studies are needed to be sure of the activities and bioactivity-directed fractionation method is needed to reveal the compounds responsible for the activity.
- 11 May 2026
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 30 (3) , 762-772
Phytochemical Analysis and In Vitro Biological Activities of Three Endemic Origanum species
Origanum species (oregano), which have been used as spices and medicines since ancient times and are one of the important riches of our country, are also known as important species in terms of the bioactive compounds they contain. In this study, phytochemical contents and biological activities of methanol extracts (OMİN, OSAM and OSOM) obtained from the aerial parts of three endemic Origanum species, Origanum minutiflorum, O. saccatum and O. solymicum, were comparatively analyzed. Extracts were obtained by maceration method. Antioxidant, anti-inflammatory and antidiabetic activities were evaluated using DPPH/ABTS radical, 5-lipoxygenase and α- glucosidase inhibition methods, respectively. Total phenol, flavonoid and triterpene contents were calculated by Folin-Ciocalteu, AlCl3 and Acetic acid/Vanillin/perchloric acid methods, respectively. Phenolic compounds of the active extract were analyzed by HPLC. OSAM with IC50 values of 13.51 µg/mL and 81.23 µg/mL exhibited the strongest antioxidant activity against DPPH and ABTS radicals. OSAM with IC50 value of 84.11 µg/mL and OSOM with IC50 value of 102.00 µg/mL showed the best inhibitory activity against α-glucosidase and 5-lipoxygenase enzymes, respectively. Total phenol and flavonoid content was highest in OSAM (132.30 and 60.32 mg/g) while total triterpene content was highest in OMIN (177.39 mg/g). In the HPLC analysis of the most active OSAM, rosmarinic acid as the major compound was detected in very high amounts (211.061 mg/g extract). These results show that OSAM has a strong antioxidant and antidiabetic activity and that other phenolic acids and flavonoids, especially rosmarinic acid, may be responsible for this activity. However, in vivo studies are needed to be sure of the activities and bioactivity-directed fractionation method is needed to reveal the compounds responsible for the activity.
- Open Access
Hidden Ethnomedicinal Diversity in a Fine-Scale Study from Konak, Eastern Anatolia
This study documents the ethnomedicinal knowledge of Konak (Malatya, Eastern Anatolia, Türkiye), a region with rich plant diversity but no prior comprehensive research. The aim of the study is to systematically document and analyze the ethnomedicinal practices of Konak village, focusing on plant taxa (species, subspecies and varieties) used, preparation methods, and therapeutic applications. Data were collected through semi-structured interviews with 68 local informants. Quantitative analysis was performed using Informant Consensus Factor (FIC) and Use Value (UV) indices. Plant specimens were collected, identified, and deposited in the herbarium. The study documented 86 plant taxa from 35 families used in 230 therapeutic applications. Lamiaceae, Asteraceae, and Rosaceae were the most represented families. High FIC values were recorded for colds (FIC = 0.95), stomach pain (FIC = 0.92), and inflammation (FIC = 0.90), indicating strong community consensus. The most frequently cited species were Origanum vulgare subsp. gracile, Mentha spp., and Rosa canina. There are novel or locally specific uses, with 13 taxa having no previously recorded ethnomedicinal applications in the reviewed literature. The findings reveal Konak as a significant repository of ethnomedicinal knowledge. High-FIC taxa represent prime candidates for phytochemical and pharmacological research to validate traditional uses and support evidence-based phytotherapy. This study enriches regional ethnopharmacological data and highlights candidate taxa for pharmacological validation.
Open AccessHidden Ethnomedicinal Diversity in a Fine-Scale Study from Konak, Eastern Anatolia
This study documents the ethnomedicinal knowledge of Konak (Malatya, Eastern Anatolia, Türkiye), a region with rich plant diversity but no prior comprehensive research. The aim of the study is to systematically document and analyze the ethnomedicinal practices of Konak village, focusing on plant taxa (species, subspecies and varieties) used, preparation methods, and therapeutic applications. Data were collected through semi-structured interviews with 68 local informants. Quantitative analysis was performed using Informant Consensus Factor (FIC) and Use Value (UV) indices. Plant specimens were collected, identified, and deposited in the herbarium. The study documented 86 plant taxa from 35 families used in 230 therapeutic applications. Lamiaceae, Asteraceae, and Rosaceae were the most represented families. High FIC values were recorded for colds (FIC = 0.95), stomach pain (FIC = 0.92), and inflammation (FIC = 0.90), indicating strong community consensus. The most frequently cited species were Origanum vulgare subsp. gracile, Mentha spp., and Rosa canina. There are novel or locally specific uses, with 13 taxa having no previously recorded ethnomedicinal applications in the reviewed literature. The findings reveal Konak as a significant repository of ethnomedicinal knowledge. High-FIC taxa represent prime candidates for phytochemical and pharmacological research to validate traditional uses and support evidence-based phytotherapy. This study enriches regional ethnopharmacological data and highlights candidate taxa for pharmacological validation.